Keryx Biopharmaceuticals (KERX)
Keryx Biopharmaceuticals Balance Sheet
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Assets | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Cash & Short Term Investments | 30.91M | 39.46M | 47.10M | 52.52M | 23.06M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Receivables | 0.064M | 0.007M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||
| Inventory | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Prepaid Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Current Assets | 0.524M | 0.534M | 0.804M | 0.368M | 0.143M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Current Assets | 31.50M | 40.00M | 47.96M | 52.90M | 23.21M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Property, Plant & Equipment | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Accumulated Depreciation | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Property, Plant & Equipment | 0.059M | 0.067M | 0.072M | 0.07M | 0.071M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Long Term Investments | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Goodwill & Intangibles | 3.208M | 3.208M | 3.208M | 3.208M | 3.208M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Long Term Assets | 0.209M | 0.209M | 0.209M | 0.209M | 0.176M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Assets | 3.476M | 3.484M | 3.489M | 3.487M | 3.455M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Assets | 34.98M | 43.49M | 51.45M | 56.39M | 26.66M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Liabilities | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Current Portion of Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Accounts Payable | 9.559M | 8.87M | 9.262M | 6.239M | 6.25M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Accrued Expenses | 0.178M | 0.897M | 0.503M | 0.353M | 0.178M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Revenues | 0.156M | 0.156M | 0.156M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Other Current Liabilities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Liabilities | 9.737M | 9.767M | 9.921M | 6.748M | 6.584M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Deferred Income Tax | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Liabilities | 2.663M | 2.674M | 2.639M | 2.651M | 2.663M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Liabilities | 2.663M | 2.674M | 2.639M | 2.651M | 2.663M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities | 12.40M | 12.44M | 12.56M | 9.399M | 9.247M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Common Shares Outstanding | 71.23M | 71.02M | 71.02M | 69.69M | 61.55M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Preferred Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Common Stock, Net | 0.071M | 0.071M | 0.071M | 0.07M | 0.062M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Additional Paid-in Capital | 401.87M | 401.22M | 400.69M | 398.54M | 365.88M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Retained Earnings | -379.00M | -369.89M | -361.51M | -351.26M | -348.17M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Treasury Stock | 0.357M | 0.357M | 0.357M | 0.357M | 0.357M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Shareholder's Equity | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 22.58M | 31.05M | 38.89M | 46.99M | 17.42M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities & Shareholder's Equity | 34.98M | 43.49M | 51.45M | 56.39M | 26.66M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |